MedTrace Logo

An Evaluation of Interlaminar Lumbar Instrumented (ILIF™)

NCT01019057 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 77

Last updated 2025-12-24

No results posted yet for this study

Summary

Patients diagnosed with single-level degenerative disc disease (DDD) of the lumbar spine undergo a posterior decompression followed by a fusion complete with a spinous process plate, graft, and a biologic.

Conditions

  • Degenerative Disc Disease

Interventions

PROCEDURE

ILIF

Interlaminar lumbar instrumented fusion (ILIF™) is a compound surgical solution to spinal stenosis, combining direct neural decompression with an allograft interspinous spacer (ExtenSure® H2) to maintain the segmental distraction, and a spinous process fixation plate (Affix™) to maintain stability for eventual segmental fusion.

Sponsors & Collaborators

  • NuVasive

    lead INDUSTRY

Principal Investigators

  • Hyun Bae, M.D · The Spine Institute in Los Angeles, CA

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01019057 on ClinicalTrials.gov